Table 3 Unstandardized regression coefficients and standard errors for all variables included in models examining metabolic and inflammatory outcome measures
Total Cholesterol (mg/dl) (n = 2134) | p | HDL - Cholesterol (mg/dl) (n = 2134) | p | LDL-Cholesterol (mg/dl) (n = 2134) | p | Triglycerides (mg/dl) (n = 2134) | p | Glycated Hemoglobin (%) (n = 2134) | p | C-Reactive Protein (mg/l) (n = 2069) | p | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age | 0.62 (0.10) | 0.000 | 0.21 (0 .04) | 0.000 | 0.43 (0.09) | 0.000 | −0.37 (0.31) | 0.233 | 0.01 (0.00) | 0.000 | 0.02 (0.02) | 0.517 |
Sex (0 = female; 1 = male) | −10.57 (3.32) | 0.002 | −12.27 (1.23) | 0.000 | −4.43 (2.78) | 0.111 | 39.15 (9.78) | 0.000 | 0.07 (0.08) | 0.423 | −2.06 (0.77) | 0.007 |
Race (0 = White; 1 = AA) | −9.00 (3.15) | 0.004 | 3.58 (1.16) | 0.002 | −6.04 (2.63) | 0.022 | −34.47 (9.26) | 0.000 | 0.24 (0.08) | 0.002 | −0.41 (0.72) | 0.569 |
Poverty Status (0 = non-poverty; 1 = poverty) | −5.08 (3.89) | 0.192 | −3.73 (1.44) | 0.010 | −3.62 (3.26) | 0.266 | 15.06 (11.46) | 0.189 | −0.01 (0.10) | 0.907 | −0.77 (0.88) | 0.383 |
Education | −0.80 (0.35) | 0.022 | 0.24 (0.13) | 0.068 | −0.58 (0.29) | 0.046 | −1.87 (1.03) | 0.069 | −0.02 (0.01) | 0.072 | −0.09 (0.08) | 0.282 |
WRAT-III Read Score | 0.08 (0.13) | 0.532 | −0.04 (0.05) | 0.421 | 0.12 (0.11) | 0.279 | −0.19 (0.39) | 0.625 | 0.00 (0.00) | 0.424 | −0.01 (0.03) | 0.824 |
Cigarette Use | −0.01 (1.25) | 0.992 | −2.42 (0.46) | 0.000 | 1.08 (1.04) | 0.301 | 12.07 (3.67) | 0.001 | −0.01 (0.03) | 0.649 | 0.43 (0.29) | 0.134 |
Alcohol Use | −0.93 (1.18) | 0.432 | 2.41 (0.44) | 0.000 | −2.95 (0.99) | 0.003 | −5.04 (3.47) | 0.147 | −0.03 (0.03) | 0.356 | −0.05 (0.28) | 0.853 |
Cocaine Use | 1.47 (2.04) | 0.472 | 2.79 (0.76) | 0.000 | −1.96 (1.71) | 0.253 | 1.14 (6.02) | 0.846 | −0.07 (0.05) | 0.159 | −0.49 (0.46) | 0.288 |
Heroin Use | −5.53 (2.45) | 0.024 | −0.54 (0.91) | 0.554 | −5.18 (2.05) | 0.012 | −3.25 (7.20) | 0.651 | 0.03 (0.06) | 0.645 | 0.67 (0.56) | 0.230 |
Marijuana Use | −0.28 (1.51) | 0.855 | 0.29 (0.56) | 0.603 | 0.46 (1.27) | 0.719 | −5.01 (4.45) | 0.261 | −0.03 (0.04) | 0.484 | 0.08 (0.34) | 0.807 |
CES-D Score | −0.14 (0.09) | 0.101 | −0.02 (0.03) | 0.481 | −0.11 (0.07) | 0.127 | 0.12 (0.25) | 0.637 | 0.00 (0.00) | 0.561 | −0.02 (0.02) | 0.269 |
Healthcare Barriers | −0.04 (0.28) | 0.876 | −0.12 (0.10) | 0.245 | 0.08 (0.24) | 0.727 | 0.66 (0.83) | 0.426 | −0.02 (0.01) | 0.007 | −0.14 (0.06) | 0.028 |
Body Mass Index | −0.02 (0.13) | 0.877 | −0.67 (0.05) | 0.000 | 0.37 (0.11) | 0.000 | 1.73 (0.37) | 0.000 | 0.02 (0.00) | 0.000 | 0.30 (0.03) | 0.000 |
MIA Cormorbidity Cluster | −8.38 (2.73) | 0.002 | −2.83 (1.01) | 0.005 | −5.76 (2.28) | 0.012 | −2.23 (8.03) | 0.781 | −0.06 (0.07) | 0.356 | 0.28 (0.61) | 0.653 |
CVD Comorbidity Cluster | −21.51 (4.82) | 0.000 | −4.42 (1.79) | 0.013 | −15.05 (4.03) | 0.000 | −13.43 (14.19) | 0.344 | −0.07 (0.12) | 0.560 | 3.60 (1.06) | 0.001 |
Antilipidemics | 7.13 (2.74) | 0.009 | −2.10 (1.01) | 0.039 | 1.27 (2.29) | 0.580 | 53.78 (8.06) | 0.000 | 0.22 (0.07) | 0.001 | −0.61 (0.62) | 0.324 |
Diabetes Medications | −7.12 (3.36) | 0.035 | −1.48 (1.25) | 0.236 | −11.33 (2.81) | 0.000 | 35.18 (9.90) | 0.000 | 2.16 (0.08) | 0.000 | 0.10 (0.75) | 0.893 |
Race x Poverty Status | 2.57 (4.96) | 0.604 | 3.94 (1.84) | 0.032 | 1.71 (4.15) | 0.680 | −18.58 (14.60) | 0.203 | 0.07 (0.12) | 0.595 | 1.12 (1.14) | 0.325 |
Sex x Race | 7.33 (4.64) | 0.115 | 1.88 (1.72) | 0.274 | 6.76 (3.89) | 0.082 | −9.14 (13.67) | 0.504 | 0.01 (0.11) | 0.914 | 0.78 (1.06) | 0.462 |
Sex x Poverty Status | 4.69 (6.12) | 0.443 | 3.78 (2.27) | 0.095 | 1.69 (5.12) | 0.741 | 17.51 (18.01) | 0.331 | 0.17 (0.15) | 0.268 | 1.05 (1.38) | 0.446 |
Sex x Race x Poverty Status | −5.93 (7.78) | 0.446 | 1.38 (2.88) | 0.633 | −5.88 (6.51) | 0.366 | −30.08 (22.90) | 0.189 | −0.22 (0.19) | 0.251 | 1.12 (1.77) | 0.525 |